JACKSONVILLE, Fla. — New research from Acosta Group highlights how the rapid adoption of GLP-1 receptor agonists is influencing far more than weight loss, triggering a broader “halo effect” that is reshaping consumer behavior across grocery, foodservice, health and beauty, and omnichannel retail.
The study, conducted ahead of the National Association of Chain Drug Stores Annual Meeting, finds that consumers using GLP-1 medications are making measurable changes to their purchasing habits, lifestyle choices and engagement with brands.
Acosta’s findings show a clear pivot toward healthier food choices. Among GLP-1 users, 55% report buying more fresh produce, while purchases of yogurt, fresh chicken and protein-focused products are also rising. At the same time, consumers are pulling back on indulgent categories, with fewer sweets, salty snacks and sugary beverages making it into shopping carts…